Estimating the benefits of mammography screening: the impact of study design.

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Estimating the benefits of mammography screening: the impact of study design. / Olsen, Anne Helene; Njor, Sisse H; Lynge, Elsebeth.

In: Epidemiology, Vol. 18, No. 4, 2007, p. 487-92.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Olsen, AH, Njor, SH & Lynge, E 2007, 'Estimating the benefits of mammography screening: the impact of study design.', Epidemiology, vol. 18, no. 4, pp. 487-92. https://doi.org/10.1097/EDE.0b013e318060cbbd

APA

Olsen, A. H., Njor, S. H., & Lynge, E. (2007). Estimating the benefits of mammography screening: the impact of study design. Epidemiology, 18(4), 487-92. https://doi.org/10.1097/EDE.0b013e318060cbbd

Vancouver

Olsen AH, Njor SH, Lynge E. Estimating the benefits of mammography screening: the impact of study design. Epidemiology. 2007;18(4):487-92. https://doi.org/10.1097/EDE.0b013e318060cbbd

Author

Olsen, Anne Helene ; Njor, Sisse H ; Lynge, Elsebeth. / Estimating the benefits of mammography screening: the impact of study design. In: Epidemiology. 2007 ; Vol. 18, No. 4. pp. 487-92.

Bibtex

@article{c9c3f9c0b24e11ddb04f000ea68e967b,
title = "Estimating the benefits of mammography screening: the impact of study design.",
abstract = "BACKGROUND: Mammography screening is justifiable only if it leads to reduction in breast cancer mortality. However, evaluation of routine screening is not straightforward, as no unscreened control group is available. We report here on a cohort study of the effect of routine mammography on breast cancer mortality, and illustrate how variations in the analytic approach can affect the conclusions. METHODS: We used data from the mammography screening program in Copenhagen, Denmark, for the period 1991-2001. We used local historical, concurrent regional, and historical regional control groups, and included only deaths from breast cancers diagnosed during the observation periods. We examined the impact of various control groups, of including all breast cancer deaths, and of using individual data versus routine statistics. RESULTS: Combining all 3 control groups gave an estimated 25% reduction in breast cancer mortality. The estimate was 20% using only a local historical control group, and 9% using only a concurrent regional control group. Including all breast cancer deaths resulted in an estimate of 21% reduction in breast cancer mortality. Using routine statistics and a concurrent regional control group resulted in an estimated increase of 6% in breast cancer mortality. CONCLUSION: Estimated changes in breast cancer mortality following the introduction of routine mammography ranged from a 25% reduction (based on the best methodology) to a 6% increase with a less rigid study design. The estimated effect of routine mammography on breast cancer mortality is thus highly dependent on study design.",
author = "Olsen, {Anne Helene} and Njor, {Sisse H} and Elsebeth Lynge",
note = "Keywords: Aged; Breast Neoplasms; Cohort Studies; Control Groups; Denmark; Female; Humans; Mammography; Mass Screening; Middle Aged; Poisson Distribution; Reproducibility of Results; Risk",
year = "2007",
doi = "10.1097/EDE.0b013e318060cbbd",
language = "English",
volume = "18",
pages = "487--92",
journal = "Epidemiology",
issn = "1044-3983",
publisher = "Lippincott Williams & Wilkins",
number = "4",

}

RIS

TY - JOUR

T1 - Estimating the benefits of mammography screening: the impact of study design.

AU - Olsen, Anne Helene

AU - Njor, Sisse H

AU - Lynge, Elsebeth

N1 - Keywords: Aged; Breast Neoplasms; Cohort Studies; Control Groups; Denmark; Female; Humans; Mammography; Mass Screening; Middle Aged; Poisson Distribution; Reproducibility of Results; Risk

PY - 2007

Y1 - 2007

N2 - BACKGROUND: Mammography screening is justifiable only if it leads to reduction in breast cancer mortality. However, evaluation of routine screening is not straightforward, as no unscreened control group is available. We report here on a cohort study of the effect of routine mammography on breast cancer mortality, and illustrate how variations in the analytic approach can affect the conclusions. METHODS: We used data from the mammography screening program in Copenhagen, Denmark, for the period 1991-2001. We used local historical, concurrent regional, and historical regional control groups, and included only deaths from breast cancers diagnosed during the observation periods. We examined the impact of various control groups, of including all breast cancer deaths, and of using individual data versus routine statistics. RESULTS: Combining all 3 control groups gave an estimated 25% reduction in breast cancer mortality. The estimate was 20% using only a local historical control group, and 9% using only a concurrent regional control group. Including all breast cancer deaths resulted in an estimate of 21% reduction in breast cancer mortality. Using routine statistics and a concurrent regional control group resulted in an estimated increase of 6% in breast cancer mortality. CONCLUSION: Estimated changes in breast cancer mortality following the introduction of routine mammography ranged from a 25% reduction (based on the best methodology) to a 6% increase with a less rigid study design. The estimated effect of routine mammography on breast cancer mortality is thus highly dependent on study design.

AB - BACKGROUND: Mammography screening is justifiable only if it leads to reduction in breast cancer mortality. However, evaluation of routine screening is not straightforward, as no unscreened control group is available. We report here on a cohort study of the effect of routine mammography on breast cancer mortality, and illustrate how variations in the analytic approach can affect the conclusions. METHODS: We used data from the mammography screening program in Copenhagen, Denmark, for the period 1991-2001. We used local historical, concurrent regional, and historical regional control groups, and included only deaths from breast cancers diagnosed during the observation periods. We examined the impact of various control groups, of including all breast cancer deaths, and of using individual data versus routine statistics. RESULTS: Combining all 3 control groups gave an estimated 25% reduction in breast cancer mortality. The estimate was 20% using only a local historical control group, and 9% using only a concurrent regional control group. Including all breast cancer deaths resulted in an estimate of 21% reduction in breast cancer mortality. Using routine statistics and a concurrent regional control group resulted in an estimated increase of 6% in breast cancer mortality. CONCLUSION: Estimated changes in breast cancer mortality following the introduction of routine mammography ranged from a 25% reduction (based on the best methodology) to a 6% increase with a less rigid study design. The estimated effect of routine mammography on breast cancer mortality is thus highly dependent on study design.

U2 - 10.1097/EDE.0b013e318060cbbd

DO - 10.1097/EDE.0b013e318060cbbd

M3 - Journal article

C2 - 17486020

VL - 18

SP - 487

EP - 492

JO - Epidemiology

JF - Epidemiology

SN - 1044-3983

IS - 4

ER -

ID: 8592439